Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/23/26
TipRanks (Fri, 23-Jan 8:55 AM ET)
VTI ETF Rebounds after Sell-Off — A Quick Snapshot for Investors, 1/22/2026
TipRanks (Thu, 22-Jan 10:17 AM ET)
Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25
TipRanks (Wed, 21-Jan 5:45 AM ET)
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/20/25
TipRanks (Tue, 20-Jan 7:26 AM ET)
PRNewswire (Mon, 12-Jan 9:00 AM ET)
Co-Diagnostics Announces Reverse Stock Split
PRNewswire (Tue, 30-Dec 9:00 AM ET)
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
PRNewswire (Mon, 29-Dec 9:00 AM ET)
PRNewswire (Thu, 18-Dec 9:00 AM ET)
PRNewswire (Wed, 17-Dec 9:00 AM ET)
Co-Diagnostics to Present on Co-Dx PCR Platform and AI Integration at Point-of-Care Testing 2025
PRNewswire (Tue, 9-Dec 9:01 AM ET)
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Co-Diagnostics trades on the stock market under the symbol CODX.
As of January 23, 2026, CODX stock price was flat at $2.36 with million shares trading.
CODX has a beta of 1.90, meaning it tends to be more sensitive to market movements. CODX has a correlation of 0.06 to the broad based SPY ETF.
CODX has a market cap of $4.94 million. This is considered a Sub-Micro Cap stock.
Last quarter Co-Diagnostics reported $145,380 in Revenue and -$4.80 earnings per share. This fell short of revenue expectation by $-154,620 and exceeded earnings estimates by $.90.
In the last 3 years, CODX traded as high as $99.90 and as low as $2.36.
The top ETF exchange traded funds that CODX belongs to (by Net Assets): VTI, VXF.
CODX has underperformed the market in the last year with a price return of -90.5% while the SPY ETF gained +15.0%. CODX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -75.3% and -61.4%, respectively, while the SPY returned +3.6% and +0.1%, respectively.
CODX support price is $2.14 and resistance is $2.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CODX shares will trade within this expected range on the day.
